Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.

Kappos L, De Stefano N, Freedman MS, Cree BAC, Radue E-W, Sprenger T, Sormani M P, Smith T, Häring DA, Meier D P, et al.

Mult Scler. 2015 Nov 19. PMID: 26585439. Abstract